Bill Rader

Bill Rader is a life-long entrepreneur who sold his first company at age 18. To date he has launched five ventures, including the most recent Efferent Labs, Inc., and orchestrated multiple M&A's. In Oct. 2014, Efferent was a winner in the worlds largest business contest 43North. Efferent Labs, Inc. is a pre-clinical stage company focused on biosensor systems for life sciences. The company's proprietary technology is showcased in our Living Biosensor System, an in-vivo, real time monitoring system for biological signaling and cellular responses. CytoComm(TM) is unique as it employs living cell lines, a powerful platform to assess cellular function. Bill started Efferent Labs after inventing the medical infusion device RxFusion in 2009. Since mid 2011, he has created alliances with major universities, merged a university sponsored startup into the company, and now hold patents to many promising technologies. These technologies are in stages from early concept through late stage development. Offices for Efferent are located in Buffalo, NY and Rochester, NY. Information available at www.efferentlabs.com  In 2015 Bill had a successful exit from the company he founded in 1998, Raland Technologies, LLC, a consulting and products company. Bill grew the company, now Raland Compliance Partners, LLC, organically as well as thru M&A. Raland Compliance Partners consults primarily to Biotechnology, Medical Device and Pharmaceutical companies in the specialty of Regulatory Consulting, Validation, Communication services. Offices are located in; Chicago, IL, Rochester, NY and Rockville, MD.  Bill sold the company in 2015 to devote all his efforts to Efferent Labs. Prior to Raland Technologies, Bill worked in a variety of positions from Consultant and Senior Engineer to Vice President. He started his tenure in the early 1980's in the engineering sector of the U.S. Navy as a Nuclear Engineering Reactor Controls member of the Submarine Fleet.  Bill holds a Bachelor of Science in Electrical Engineering, is a member of Harvard Business School, Business Innovations in Global Healthcare class of 2015, and a graduate of the University at Buffalo, School of Management. He is a regular paid Contributor to Forbes Media and, a NYBio Fellow, along with being a member of many industry organizations including ISPE, PDA, IEEE, MedTech, Tech Council/MDBio, and ISA.